(Q30371759)

21 June 2017

title

Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines. (English)

1 reference

21 June 2017

Alan Yung-Chih Hu

1

1 reference

21 June 2017

Tsai-Chuan Weng

2

1 reference

21 June 2017

Yu-Fen Tseng

3

1 reference

21 June 2017

Yu-Shuan Chen

4

1 reference

21 June 2017

Chia-Hann Wu

5

1 reference

21 June 2017

Sigrid Hsiao

6

1 reference

21 June 2017

Ai-Hsiang Chou

7

1 reference

21 June 2017

Hsin-Ju Chao

8

1 reference

21 June 2017

Anna Gu

9

1 reference

21 June 2017

Suh-Chin Wu

10

1 reference

21 June 2017

Pele Chong

11

1 reference

21 June 2017

Min-Shi Lee

12

1 reference

21 June 2017

language of work or name

English

0 references

publication date

30 August 2008

1 reference

21 June 2017

1 reference

21 June 2017

volume

26

1 reference

21 June 2017

issue

45

1 reference

21 June 2017

page(s)

5736-5740

1 reference

Development of a mammalian cell (Vero) derived candidate influenza virus vaccine

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.015

The role of cell culture vaccines in the control of the next influenza pandemic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.015

Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.015

Enhanced growth of seed viruses for H5N1 influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.015

Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.015

Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.015

Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.015

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.015

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.015

An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.015

H5N1 vaccines: how prepared are we for a pandemic?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.015

Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.015

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.015

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.015

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.015

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.015

Inactivated whole virus influenza A (H5N1) vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.08.015

10.1016/J.VACCINE.2008.08.015

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference